SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Octane Biotech and Currus Biologics Automate CUR-001 Manufacturing

Octane Biotech and Currus Biologics automated manufacturing of CUR-001 CAR T-cell therapy on the Cocoon platform.

Related stories